# Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

> **NCT01533285** · EARLY_PHASE1 · COMPLETED · sponsor: **Janssen Pharmaceutica N.V., Belgium** · enrollment: 40 (actual)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Salmonella typhi vaccine (Typhim Vi)

## Key facts

- **NCT ID:** NCT01533285
- **Lead sponsor:** Janssen Pharmaceutica N.V., Belgium
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-05
- **Primary completion:** 2013-11
- **Final completion:** 2013-11
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2014-03-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01533285

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01533285, "Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT01533285. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*